Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

Kangmei Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,035	32,441	25,787	30,501	42,839	13,330
Market Cap Growth	-3.69%	25.81%	-15.46%	-28.80%	221.38%	-28.15%
Enterprise Value	26,322	31,918	24,904	28,797	76,028	47,878
Last Close Price	1.95	2.34	1.86	2.20	3.09	2.68
PE Ratio	2813.71	3783.85	251.53	-	5.41	-
Forward PE	-	2.56	2.56	2.56	2.56	2.56
PS Ratio	5.11	6.25	5.29	7.30	10.32	2.46
PB Ratio	3.75	4.50	3.64	4.37	4.30	-1.28
P/TBV Ratio	4.05	4.87	4.00	4.83	4.64	-
P/FCF Ratio	-	-	-	-	1006.12	18.27
P/OCF Ratio	-	-	-	-	199.99	12.92
PEG Ratio	-	0.53	0.53	0.53	0.53	0.53
EV/Sales Ratio	4.98	6.15	5.11	6.89	18.31	8.85
EV/EBITDA Ratio	-	-	52.89	-	-	-
EV/EBIT Ratio	-	-	138.67	-	-	-
EV/FCF Ratio	-104.85	-	-	-	1785.59	65.62
Debt / Equity Ratio	0.02	0.02	0.04	0.04	0.02	-2.09
Debt / EBITDA Ratio	-	-	0.49	-	-	-
Debt / FCF Ratio	-	-	-	-	4.82	29.78
Asset Turnover	0.38	0.37	0.33	0.27	0.17	0.11
Inventory Turnover	1.72	1.76	1.54	1.26	0.91	1.57
Quick Ratio	0.70	0.74	0.69	0.82	1.00	0.54
Current Ratio	1.19	1.17	1.12	1.36	1.68	0.80
Return on Equity (ROE)	0.17%	0.17%	1.47%	-31.78%	-	-607.26%
Return on Assets (ROA)	-1.57%	-1.84%	0.76%	-4.17%	-7.71%	-34.21%
Return on Capital (ROIC)	-2.99%	-3.52%	1.54%	-7.46%	-17.72%	-51.60%
Return on Capital Employed (ROCE)	-	-	2.20%	-	-	-
Earnings Yield	0.04%	0.03%	0.40%	-8.81%	18.48%	-233.19%
FCF Yield	-0.93%	-1.51%	-1.62%	-2.62%	0.10%	5.47%
Payout Ratio	7.81%	8.75%	-	-	0.17%	-
Buyback Yield / Dilution	-62.20%	-39.38%	27.54%	-1.85%	-0.55%	-179.83%
Total Shareholder Return	-	-39.38%	27.54%	-1.85%	-0.55%	-179.83%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.